Edition:
United States

TherapeuticsMD Inc (TXMD.A)

TXMD.A on American Stock Exchange

6.41USD
23 Sep 2016
Change (% chg)

$0.15 (+2.40%)
Prev Close
$6.26
Open
$6.26
Day's High
$6.42
Day's Low
$6.18
Volume
204,482
Avg. Vol
170,879
52-wk High
$11.26
52-wk Low
$5.19

TXMD.A

Chart for TXMD.A

About

TherapeuticsMD, Inc. is a women's healthcare product company. The Company's segment is creating and commercializing products for women. It is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. Its drug candidates are created using its... (more)

Overall

Beta: 0.92
Market Cap(Mil.): $1,259.52
Shares Outstanding(Mil.): 196.49
Dividend: --
Yield (%): --

Financials

  TXMD.A Industry Sector
P/E (TTM): -- 36.61 36.60
EPS (TTM): -0.42 -- --
ROI: -68.31 14.46 13.91
ROE: -68.60 15.26 14.82

BRIEF-TherapeuticsMD's NDA for Yuvvexy accepted by FDA

* Announces FDA acceptance of new drug application (NDA) and prescription drug user fee act (PDUFA) date for Yuvvexy(TM)(TX-004HR)

Sep 19 2016

BRIEF-Therapeuticsmd reports Q2 loss per share $0.11

* Therapeuticsmd announces second quarter 2016 financial results

Aug 04 2016

BRIEF-TherapeuticsMD Inc announces new drug application submission for Yuvvexy

* Says NDA submission includes all three doses of Yuvvexy (4 mcg, 10 mcg and 25 mcg) that were evaluated in rejoice trial Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jul 07 2016

BRIEF-TherapeuticsMD announces filing timeline for Yuvvexy (TX-004HR) new drug application

* Expects NDA for Yuvvexy (TX-004HR), to be submitted to FDA on or before July 15, 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Jun 29 2016

BRIEF-TherapeuticsMD Q1 loss per share $0.11

* TherapeuticsMD announces first quarter 2016 financial results

May 03 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.